[{"indications": "Indications\u00a0see under Dose", "name": "IBANDRONIC ACID", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "6 Endocrine system", "6.6 Drugs affecting bone metabolism", "6.6.2 Bisphosphonates and other drugs affecting bone metabolism", "Bisphosphonates", "IBANDRONIC ACID"], "cautions": "Cautions\u00a0consider dental check-up before initiating\r\nbisphosphonate (risk of osteonecrosis of\r\nthe jaw, see Bisphosphonates: Osteonecrosis\r\nof the Jaw); atypical femoral fractures, see MHRA/CHM advice; monitor renal function and serum calcium, phosphate\r\nand magnesium; cardiac disease (avoid fluid overload); interactions: Appendix 1 (bisphosphonates)", "side-effects": "Side-effects\u00a0hypocalcaemia, hypophosphataemia, influenza-like\r\nsymptoms (including fever, chills, and muscle pain), bone pain; oesophageal\r\nreactions (see below), diarrhoea, nausea, vomiting, gastritis, abdominal\r\npain, dyspepsia, pharyngitis; headache, asthenia, rash; rarely anaemia, atypical femoral fractures (see MHRA/CHM advice),\r\nhypersensitivity reactions (pruritus, bronchospasm and angioedema\r\nreported); urticaria; injection-site reactions; very rarely osteonecrosis of the jaw (see Bisphosphonates: Osteonecrosis\r\nof the Jaw)Oesophageal reactions\u00a0Severe oesophageal reactions\r\nreported with all oral bisphosphonates; patients should be advised to stop tablets and seek medical attention\r\nfor symptoms of oesophageal irritation such as dysphagia, pain on\r\nswallowing, retrosternal pain, or heartburn", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/129542.htm", "doses": ["Reduction of bone damage in bone metastases in breast\r\ncancer, by mouth, 50\u00a0mg daily, or by intravenous infusion, 6\u00a0mg every 3\u20134 weeks", "Hypercalcaemia of malignancy by intravenous infusion, according to serum calcium concentration, 2\u20134\u00a0mg in single infusion ", "Treatment of postmenopausal osteoporosis, by mouth, 150\u00a0mg once a month or by intravenous injection over 15\u201330\u00a0seconds, 3\u00a0mg every 3 months", "child not recommended", "Tablets should be swallowed whole\r\nwith plenty of water while sitting or standing; to be taken on an\r\nempty stomach at least 30 minutes (ibandronic acid tablets, 50\u00a0mg)\r\nor 1 hour (Bonviva\u00ae tablets, 150\u00a0mg) before first\r\nfood or drink (other than water) of the day, or another oral medicine;\r\npatient should stand or sit upright for at least 1 hour after taking\r\ntablet"], "pregnancy": "Pregnancy\u00a0avoid"}]